abstract |
The present invention relates to a group of pteridine derivatives, pharmaceutically acceptable salts, N-oxides, solvates, dihydro- and tetrahydro for the manufacture of a medicament for the prevention or treatment of TNF-α related diseases. -The use of derivatives and enantiomers. |